News Xalkori Approved for Anaplastic Large Cell Lymphoma in Children, Young Adults By Brian Park, PharmD Publish Date January 15, 2021
News Overall Survival Data Added to Nubeqa Prescribing Information By Brian Park, PharmD Publish Date January 8, 2021
News Statins May Benefit Patients Receiving ADT for Relapsed Prostate Cancer By Jody A. Charnow Publish Date January 8, 2021
Drugs in the Pipeline Tiragolumab Gets Breakthrough Therapy Status for PD-L1-High NSCLC By Brian Park, PharmD Publish Date January 6, 2021
News Orgovyx Now Available for Advanced Prostate Cancer By Brian Park, PharmD Publish Date January 6, 2021
News Opdivo No Longer FDA-Approved for Small Cell Lung Cancer By Brian Park, PharmD Publish Date January 5, 2021
Drugs in the Pipeline Lorlatinib Under Review for Previously Untreated ALK-Positive NSCLC By Brian Park, PharmD Publish Date January 4, 2021
News Tagrisso Approved as Adjuvant Therapy for Early-Stage EGFR-Mutant NSCLC By Brian Park, PharmD Publish Date December 22, 2020
News Xpovio Multiple Myeloma Indication Expanded By Brian Park, PharmD Publish Date December 22, 2020
News Orgovyx Approved for Advanced Prostate Cancer By Diana Ernst, RPh Publish Date December 21, 2020
Drugs in the Pipeline FDA Accepts and Grants Priority Review to New sBLA for Keytruda By Steve Duffy Publish Date December 21, 2020
ASH 2020 Treatment With High-Dose Melphalan Linked to Mutational Load in Multiple Myeloma By Leah Lawrence Publish Date December 6, 2020
News Gavreto Gets Accelerated Approval for RET-Altered Thyroid Cancers By Brian Park, PharmD Publish Date December 3, 2020
News Gallium 68 PSMA-11 Approved for Prostate Cancer Detection By Brian Park, PharmD Publish Date December 2, 2020
News Novel Treatment Gains Accelerated Approval for Relapsed/Refractory Neuroblastoma By Steve Duffy Publish Date November 30, 2020
Drugs in the Pipeline Loncastuximab Tesirine Gets Priority Review for Relapsed/Refractory Diffuse Large B-Cell Lymphoma By Brian Park, PharmD Publish Date November 24, 2020